Equinox Gold Corp. Common Shares vs Cassava Sciences Inc — how do they compare? Equinox Gold Corp. Common Shares trades at $11.4 (market cap $12.80B), while Cassava Sciences Inc trades at $0.82 (market cap $39.40M). The key difference: Equinox Gold Corp. Common Shares is far larger — about 324.9× Cassava Sciences Inc's market cap, and Equinox Gold Corp. Common Shares pays a 0.48% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Equinox Gold Corp. Common Shares for 0 Days and Cassava Sciences Inc for 37 Days on average.
| EQX | FLNA | |
|---|---|---|
Market Cap | $12.80B | $39.40M |
Volume | 8,210,537 | 759,018 |
Sector | Basic Materials | Health |
52-Week High | $18.76 | $4.64 |
52-Week Low | $8.62 | $0.68 |
Typical Hold Time | 0 Days | 37 Days |
Enterprise Value | $12.90B | -$43.28M |
Dividend Yield | 0.48% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
FLNA trades at $0.8136, down 7.01% today, with a bearish technical signal from moving averages. The company shows negative profitability with ROE at -55.79% and ROA at -35.34%, though it has beaten EPS estimates for three consecutive quarters. Recent FDA approval to lift the clinical hold on simufilam for epilepsy research provides a positive catalyst, with patient screening expected by Q1 2027.
Despite operational losses and negative cash flow, analyst consensus is bullish with 8 buy ratings versus 4 hold. The key investment opportunity lies in the clinical progress of simufilam, while risks include sustained cash burn and reliance on successful drug development outcomes in a competitive biotech landscape.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Equinox Gold is a gold mining company with operations in the Americas. It produces gold and develops additional mining projects.
Read more on EQX →Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →